Eric Walk
Chief Medical Officer @PathAI
Signup · Get unlimited contacts
WORK HISTORY
Chief Medical Officer @PathAI
Boston, MA, US
PathAI\'s mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning.We are a company of diverse employees with a wide range of backgrounds and experiences. Our world class team is passionate about solving challenging problems and making a huge impact. Our office is located in the heart of Fenway. PathAI was recently voted one of BBJ\'s Best Placesto Work!
EDUCATION
The Johns Hopkins University
Bachelor of Arts, Natural Science Area
Geisel School of Medicine at Dartmouth
Medicine
University of Virginia
Doctor of Medicine (M.D.), Medicine
SKILLS
ABOUT ERIC WALK
Dr. Eric Walk is Chief Medical Officer at PathAI in Boston, MA. Eric has over 20 years of experience in precision medicine, oncology drug development and IVD companion diagnostics development. Prior to joining PathAI, he was Chief Medical and Scientific Officer at Roche Tissue Diagnostics/Ventana Medical Systems, where he led Medical & Scientific Affairs, overseeing the validation and FDA clearance/approval of over 20 510k and PMA IVD assays, companion diagnostics and digital pathology algorithms. Eric began his industry career at Novartis Oncology, where he held positions in Early Clinical Development and Translational Medicine, working to implement biomarker and precision medicine strategies for early and late stage targeted oncology therapeutics.Eric is a Phi Beta Kappa graduate of Johns Hopkins University and holds a MD degree from the University of Virginia School of Medicine. He is board certified in Anatomic and Clinical Pathology and is a Fellow of the College of American Pathologists (CAP). He currently is a member of the CAP Computational Pathology Committee (DCPC).Selected PublicationsBrodsky V, Ullah E, Bychkov A, Song A, Walk E et al. Generative Artificial Intelligence in Anatomic Pathology. Arch Pathol Lab Med. 2025 (online ahead of print). https://meridian.allenpress.com/aplm/article/doi/10.5858/arpa.20••••15-RA/505319/Generative-Artificial-Intelligence-in-AnatomicWalk, E. Learning the Language: The Importance of AI Fluency in the Era of Digital and Computational Pathology. The Pathologist 2024. Accessed online April 4th, 2024. https://thepathologist.com/inside-the-lab/learning-the-languageEnfield K, Walk E, Swanton C et al. Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer. Cancer Discov. 2024 Apr 6. doi: 10.1158/21••••90.CD-23-1380. Online ahead of print.Willis J, Eyerer F, Walk E, Vasalos P, Bradshaw G, Yohe S, Laser J; CompanionDiagnostics: Lessons Learned and Path Forward From the Programmed Death Ligand-1Rollout. Arch Pathol Lab Med. 2023 Jan 1;147(1):62-70.Eyerer F, Bradshaw G, Vasalos P, Laser J, Chang C, Kim A, Olson D, Paler R, Rosenbaum J, Walk E, et al. Getting Your Laboratory on Track With Neurotrophic Receptor Tyrosine Kinase. Arch Pathol Lab Med 2022 (online ahead of print).Walk E, Yohe S, Schade A, et al. The Cancer Immunotherapy Biomarker Testing Landscape. Arch Pathol Lab Med. 2020 Jun;144(6):706-724.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.